We are live on ! Find out more
WP

Waycross Partners Portfolio holdings

AUM $1.05B
1-Year Est. Return 20.92%
This Fund
S&P 500
This Quarter Est. Return
+8.2%
1 Year Est. Return
+20.92%
3 Year Est. Return
+78.91%
5 Year Est. Return
+114.23%
10 Year Est. Return
AUM
$179M
AUM Growth
+$18.9M
Cap. Flow
+$8.74M
Cap. Flow %
4.87%
Top 10 Hldgs %
36.13%
Holding
116
New
18
Increased
18
Reduced
21
Closed
24

Top Buys

Rank Stock Value
1
LLY icon
Eli Lilly
LLY
+$3.05M
2
ADBE icon
Adobe
ADBE
+$2.71M
3
UNH icon
UnitedHealth
UNH
+$1.56M
4
ULTA icon
Ulta Beauty
ULTA
+$1.46M
5
PXD
Pioneer Natural Resource Co.
PXD
+$1.35M

Top Sells

Rank Stock Value
1
DE icon
Deere & Co
DE
+$5.18M
2
BURL icon
Burlington
BURL
+$3.11M
3
BLK icon
Blackrock
BLK
+$1.25M
4
KNX icon
Knight Transportation
KNX
+$912K
5
AXP icon
American Express
AXP
+$858K

Sector Composition

Rank Sector Weight
1 Technology 21.4%
2 Financials 18.58%
3 Healthcare 16.35%
4 Consumer Discretionary 12.01%
5 Industrials 11.42%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
NCLH icon
76
Norwegian Cruise Line
NCLH
$9.57B
$414K 0.23%
15,000
DXCM icon
77
DexCom
DXCM
$29.1B
$395K 0.22%
+4,400
New +$413K
ADSK icon
78
Autodesk
ADSK
$51.2B
$388K 0.22%
1,400
BMRN icon
79
BioMarin Pharmaceuticals
BMRN
$12B
$347K 0.19%
4,600
SBUX icon
80
Starbucks
SBUX
$118B
$303K 0.17%
+2,775
New +$291K
CAKE icon
81
Cheesecake Factory
CAKE
$4.92B
$290K 0.16%
+4,950
New +$250K
BMY icon
82
Bristol-Myers Squibb
BMY
$129B
$288K 0.16%
4,557
JNJ icon
83
Johnson & Johnson
JNJ
$642B
$279K 0.16%
1,700
SAGE
84
DELISTED
Sage Therapeutics
SAGE
$277K 0.15%
+3,700
New +$303K
RTX icon
85
RTX Corp
RTX
$292B
$243K 0.14%
3,151
PM icon
86
Philip Morris
PM
$314B
$144K 0.08%
1,619
XOM icon
87
ExxonMobil
XOM
$655B
$117K 0.07%
2,090
GOOG icon
88
Alphabet (Google) Class C
GOOG
$4.08T
$108K 0.06%
1,040
MDLZ icon
89
Mondelez International
MDLZ
$84.1B
$97K 0.05%
1,660
MO icon
90
Altria Group
MO
$126B
$66K 0.04%
1,295
PSX icon
91
Phillips 66
PSX
$83.5B
$41K 0.02%
500
KHC icon
92
Kraft Heinz
KHC
$32.8B
$22K 0.01%
553
AIG icon
93
American International
AIG
$42.8B
-16,893
Closed -$640K
AXP icon
94
American Express
AXP
$226B
-7,100
Closed -$858K
BBAX icon
95
JPMorgan BetaBuilders Developed Asia Pacific-ex Japan ETF
BBAX
$6.66B
-148
Closed -$8K
BBCA icon
96
JPMorgan BetaBuilders Canada ETF
BBCA
$10.9B
-193
Closed -$10K
BBEU icon
97
JPMorgan BetaBuilders Europe ETF
BBEU
$9.16B
-253
Closed -$13K
BBJP icon
98
JPMorgan BetaBuilders Japan ETF
BBJP
$17B
-353
Closed -$20K
BIIB icon
99
CALL
Biogen
BIIB
$31.8B
-5,000
Closed -$1.22M
BIIB icon
100
PUT
Biogen
BIIB
$31.8B
-5,000
Closed -$1.22M

Similar funds

Waycross Partners's Q1 2021 Portfolio in Review

As of Q1 2021, Waycross Partners held 116 positions worth $179M, up 12% from $160M the previous quarter. Its ten largest holdings account for 36% of the portfolio.

Waycross Partners deployed $8.74M of net new capital in Q1 2021, opening 18 new positions and adding to 18 existing holdings. Its largest new stake was Eli Lilly: 15,613 shares worth $2.92M.

By sector, the portfolio is most concentrated in Technology at 21% of assets, up from 20% a quarter earlier, followed by Financials and Healthcare.

On the sell side, the largest reduction was Deere & Co, an estimated $5.18M trimmed.

  • Waycross Partners's largest Q1 2021 buy was Eli Lilly: 15,613 shares worth $2.92M.
  • Waycross Partners added most to Adobe in Q1 2021, an estimated $2.71M increase.
  • Waycross Partners's biggest Q1 2021 reduction was Deere & Co, cutting an estimated $5.18M.
  • Waycross Partners fully exited Burlington in Q1 2021, selling an estimated $3.11M.
  • Waycross Partners's ten largest holdings make up 36% of its $179M portfolio in Q1 2021.
  • Waycross Partners opened 18 new positions and closed 24 in Q1 2021.
  • Waycross Partners's portfolio value rose 12% quarter-over-quarter to $179M.

Based on Waycross Partners's 13F filing for Q1 2021, filed 12 May 2021.